Alexithymia, suicide ideation and homocysteine levels in drug naïve patients with major depression: a study in the real world clinical practice

Clinical Psychopharmacology and Neuroscience

Volumn 17, Issue 2, 2019, Pages 318-322

  De Berardis, Domenico ^a,b   Olivieri, Luigi ^a   Rapini, Gabriella ^a   Di Natale, Serena ^a   Serroni, Nicola ^a   Fornaro, Michele ^c,d   Orsolini, Laura ^d,e   Valchera, Alessandro ^d,f   Carano, Alessandro ^g   Vellante, Federica ^a,b   Varasano, Paola Annunziata ^a   Pressanti, Gabriella Lucidi ^a   Serafini, Gianluca ^h   Pompili, Maurizio ⁱ   Martinotti, Giovanni ^b   Di Giannantonio, Massimo ^b  

^a G Mazzini Hospital   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d Polyedra   (Italy)

^e UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^f Hermanas Hospitalarias   (Italy)

^g National Health Service   (Italy)

^h UNIVERSITY OF GENOA   (Italy)

ⁱ SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Affective symptoms; Alexithymia; Depression; Homocysteine; Suicidal ideation

Indexed keywords

ANTIDEPRESSANT AGENT; HOMOCYSTEINE;

ADULT; ALEXITHYMIA; AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MELANCHOLIA; MENTAL FUNCTION ASSESSMENT; MENTAL PATIENT; OUTPATIENT; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SCALE OF SUICIDE IDEATION; SUICIDAL IDEATION; TORONTO ALEXITHYMIA SCALE;

EID: 85065237972     PISSN: 17381088     EISSN: 20934327     Source Type: Journal    
DOI: 10.9758/cpn.2019.17.2.318     Document Type: Article

References (34)

1. Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, et al. Major depressive disorder. Nat Rev Dis Primers 2016;2:16065.
2. Li S, Zhang B, Guo Y, Zhang J. The association between alexithymia as assessed by the 20-item Toronto Alexithymia Scale and depression: A meta-analysis. Psychiatry Res 2015;227: 1-9.
3. Honkalampi K, Koivumaa-Honkanen H, Lehto SM, Hintikka J, Haatainen K, Rissanen T, et al. Is alexithymia a risk factor for major depression, personality disorder, or alcohol use disorders? A prospective population-based study. J Psychosom Res 2010;68:269-273.
4. Luminet O, Bagby RM, Taylor GJ. An evaluation of the absolute and relative stability of alexithymia in patients with major depression. Psychother Psychosom 2001;70:254-260.
5. Assies J, Mocking RJ, Lok A, et al. Erythrocyte fatty acid profiles and plasma homocysteine, folate and vitamin B6 and B12 in recurrent depression: Implications for co-morbidity with cardiovascular disease. Psychiatry Res 2015;229:992-998.
6. Ford AH, Flicker L, Singh U, Hirani V, Almeida OP. Homocysteine, depression and cognitive function in older adults. J Affect Disord 2013;151:646-651.
7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 4th ed. Washington, DC:American Psychiatric Association;2000.
8. First MB, Gibbon M, Spitzer RL, Williams JBW; Department of Biometrics Research, New York State Psychiatric Institute. SCID-I User's guide for the structured clinical interview for DSM-IV-TR Axis I disorders: SCID 101 for DSM-IV. New York:New York State Psychiatric Institute;2002.
9. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296.
10. Bressi C, Taylor G, Parker J, Bressi S, Brambilla V, Aguglia E, et al. Cross validation of the factor structure of the 20-item Toronto alexithymia scale: an Italian multicenter study. J Psychosom Res 1996;41:551-559.
11. Bagby RM, Taylor GJ, Parker JD. The twenty-item Toronto Alexithymia Scale-II. Convergent, discriminant, and concurrent validity. J Psychosom Res 1994;38:33-40.
12. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol 1979;47:343-352.
13. Freyberger H. Supportive psychotherapeutic techniques in primary and secondary alexithymia. Psychother Psychosom 1977;28:337-342.
14. Na KS, Oh SJ, Jung HY, Irene Lee S, Kim YK, Han C, et al. Alexithymia and low cooperativeness are associated with suicide attempts in male military personnel with adjustment disorder: a case-control study. Psychiatry Res 2013;205:220-226.
15. Martin JB, Pihl RO. The stress-alexithymia hypothesis: theorectical and empirical considerations. Psychother Psychosom 1985;43:169-176.
16. Folstein M, Liu T, Peter I, Buell J, Arsenault L, Scott T, et al. The homocysteine hypothesis of depression. Am J Psychiatry 2007;164:861-867.
17. Karas Kuẑeli?ki N. S-adenosyl methionine in the therapy of depression and other psychiatric disorders. Drug Dev Res 2016;77:346-356.
18. Vargas HO, Nunes SO, de Castro MR, Vargas MM, Barbosa DS, Bortolasci CC, et al. Oxidative stress and inflammatory markers are associated with depression and nicotine dependence. Neurosci Lett 2013;544:136-140.
19. Zhou SJ, Zhang LG, Chen HM, Li JY, Li R, Zhang XM, et al. Prevalence and clinical-demographic correlates of hyperhomocysteinemia in inpatients with bipolar disorder in a Han Chinese population. Psychiatry Res 2018;259:364-369.
20. Mabrouk H, Douki W, Mechri A, Younes MK, Omezzine A, Bouslama A, et al. [Hyperhomocysteinemia and schizophrenia: case control study]. Encephale 2011;37:308-313. French.
21. Meier C, Harbrecht U, Liedtke R, Oldenburg J, Conrad R, Imbierowicz K, et al. Relative hyperhomocysteinemia in patients with panic disorder: a case-control study. Neuropsychobiology 2010;62:164-170.
22. Narayan SK, Verman A, Kattimani S, Ananthanarayanan PH, Adithan C. Plasma homocysteine levels in depression and schizophrenia in South Indian Tamilian population. Indian J Psychiatry 2014;56:46-53.
23. Kamath AF, Chauhan AK, Kisucka J, Dole VS, Loscalzo J, Handy DE, et al. Elevated levels of homocysteine compromise blood-brain barrier integrity in mice. Blood 2006; 107:591-593.
24. Beard RS Jr, Reynolds JJ, Bearden SE. Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions. Blood 2011;118:2007-2014.
25. Obeid R, McCaddon A, Herrmann W. The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases. Clin Chem Lab Med 2007;45:1590-1606.
26. Herrmann W, Lorenzl S, Obeid R. [Review of the role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders-current evidence and preliminary recommendations]. Fortschr Neurol Psychiatr 2007;75:515-527. German.
27. Permoda-Osip A, Dorszewska J, Skibinska M, Chlopocka-Wozniak M, Rybakowski JK. Hyperhomocysteinemia in bipolar depression: clinical and biochemical correlates. Neuropsychobiology 2013;68:193-196.
28. Lippi G, Plebani M. Hyperhomocysteinemia in health and disease: where we are now, and where do we go from here? Clin Chem Lab Med 2012;50:2075-2080.
29. Muntjewerff JW, Kahn RS, Blom HJ, den Heijer M. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry 2006;11: 143-149.
30. Iqbal MP, Lindblad BS, Mehboobali N, Yusuf FA, Khan AH, Iqbal SP. Folic acid and vitamin B6 deficiencies related hyperhomocysteinemia in apparently healthy Pakistani adults; is mass micronutrient supplementation indicated in this population? J Coll Physicians Surg Pak 2009;19:308-312.
31. Taysi S, Keles MS, Gumustekin K, Akyuz M, Boyuk A, Cikman O, et al. Plasma homocysteine and liver tissue S-adenosylmethionine, S-adenosylhomocysteine status in vitamin B6-deficient rats. Eur Rev Med Pharmacol Sci 2015;19:154-160.
32. De Berardis D, Marini S, Serroni N, Rapini G, Iasevoli F, Valchera A, et al. S-adenosyl-L-methionine augmentation in patients with stage II treatment-resistant major depressive disorder: an open label, fixed dose, single-blind study. ScientificWorldJournal 2013;2013:204649.
33. De Berardis D, Orsolini L, Serroni N, Girinelli G, Iasevoli F, Tomasetti C, et al. A comprehensive review on the efficacy of S-adenosyl-L-methionine in major depressive disorder. CNS Neurol Disord Drug Targets 2016;15:35-44.
34. Walterfang M, Bonnot O, Mocellin R, Velakoulis D. The neuropsychiatry of inborn errors of metabolism. J Inherit Metab Dis 2013;36:687-702.